Atherectomy Devices Market Size, Share, Growth, and Industry Analysis, By Type (Directional Atherectomy Devices, Orbital Atherectomy Devices, Rotational Atherectomy Devices, Laser Atherectomy Devices), By Application (Hospitals, ASCs, Clinics), Regional Insights and Forecast From 2026 To 2035

Atherectomy Devices Market Overview

The global Atherectomy Devices Market size is anticipated to be valued at USD 1228.19 Million in 2026 and is projected to grow to USD 1673.94 Million by 2035, registering a CAGR of 3.5% during the forecast period from 2026 to 2035. Market growth is supported by increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive vascular procedures, technological advancements in catheter-based treatment solutions, and growing demand for effective plaque removal devices. 

The Atherectomy Devices Market focuses on minimally invasive medical devices designed to remove atherosclerotic plaque from blood vessels and improve blood flow in patients with peripheral and coronary artery diseases. These devices support physicians in treating complex vascular blockages through advanced plaque removal technologies. Directional Atherectomy Devices represent approximately 35% market share due to targeted plaque removal capability, clinical adoption, and procedural flexibility. Manufacturers are focusing on advanced catheter designs, improved navigation systems, and enhanced treatment accuracy. Increasing prevalence of vascular disorders, rising demand for minimally invasive procedures, and technological advancements in cardiovascular care are strengthening global Atherectomy Devices Market development.

The USA Atherectomy Devices Market is supported by advanced healthcare infrastructure, increasing adoption of minimally invasive vascular procedures, and strong demand for cardiovascular treatment technologies. Hospitals and specialized vascular centers are investing in advanced atherectomy systems to improve treatment outcomes and procedural efficiency. Companies are focusing on innovative catheter technologies, improved device navigation, and enhanced safety features. Demand is increasing due to the growing burden of peripheral artery disease and the need for effective plaque removal solutions. The market benefits from clinical innovation, physician expertise, and adoption of advanced interventional cardiology procedures across hospitals, ambulatory surgical centers, and specialized clinics.

Key Findings

• Market Size and Forecast: Atherectomy Devices Market value line USD 1228.19 Million in 2026 and is projected to grow to USD 1673.94 Million by 2035, registering a CAGR of 3.5%.
• Type Leadership: Directional Atherectomy Devices lead with 35% market share, supported by targeted plaque removal and clinical adoption.
• Application Leadership: Hospitals lead with 60% market share, driven by advanced vascular procedures and specialized medical infrastructure.
• Key Company Landscape: Boston Scientific and Medtronic strengthen market position through innovation, vascular technologies, and product development expertise.
• Fastest Growing Region: North America leads with 45% market share, supported by healthcare investment and cardiovascular procedure adoption.
• Key Trends: Advanced catheter technologies, minimally invasive procedures, and improved imaging systems are shaping atherectomy innovation.

Latest Trends

The Atherectomy Devices Market is evolving through technological advancements in catheter systems, minimally invasive procedures, improved imaging capabilities, and enhanced treatment precision. Healthcare providers are increasingly adopting atherectomy devices because they enable effective plaque removal while reducing the need for complex surgical interventions. Directional Atherectomy Devices remain an important category due to their ability to selectively remove plaque and support vessel preparation. Manufacturers are developing advanced designs focused on flexibility, accuracy, and patient safety.

Digital healthcare integration and improved procedural visualization are becoming important trends in vascular treatment. Companies are investing in next-generation devices with improved navigation capabilities, smaller profiles, and enhanced compatibility with complex vascular conditions. Rising awareness of peripheral artery disease and increasing cardiovascular care requirements are supporting demand for advanced treatment options. Hospitals and ambulatory surgical centers are adopting innovative atherectomy systems to improve procedural outcomes. Research and development activities are focused on improving device performance, reducing procedural complications, and expanding treatment applications. The increasing preference for minimally invasive cardiovascular procedures continues driving innovation within the global Atherectomy Devices Market.

Market Dynamics

DRIVER

"Increasing prevalence of vascular diseases and demand for minimally invasive treatments."

The rising incidence of peripheral artery disease and other vascular conditions is a major driver of the Atherectomy Devices Market. Hospitals account for approximately 60% of market demand due to their advanced infrastructure, specialized vascular departments, and ability to perform complex procedures. Atherectomy devices provide physicians with effective plaque removal solutions while supporting minimally invasive treatment approaches. Increasing healthcare expenditure, aging populations, and growing awareness of cardiovascular disease management are encouraging adoption of advanced vascular technologies. Manufacturers are developing innovative devices with improved flexibility, precision, and safety features. Hospitals are investing in advanced interventional equipment to improve patient outcomes and procedural efficiency. Companies are focusing on expanding product portfolios, improving clinical performance, and developing next-generation catheter systems. The continued shift toward minimally invasive cardiovascular procedures is strengthening demand for atherectomy devices globally.

RESTRAINT

"High device costs and procedural complexity limit adoption."

The Atherectomy Devices Market faces challenges related to high equipment costs, specialized training requirements, and procedural complexity. Orbital Atherectomy Devices represent approximately 25% market share and require advanced operational expertise for effective clinical use. Hospitals and healthcare facilities must invest in specialized equipment, physician training, and supporting technologies. Cost considerations can influence adoption, particularly in smaller healthcare facilities with limited budgets. Regulatory requirements and approval processes can also affect product availability and market expansion. Manufacturers need continuous investment in research, clinical studies, and product improvements to address these challenges. Healthcare providers require skilled professionals to operate advanced atherectomy systems effectively. Companies are focusing on improving device usability, reducing procedural complexity, and developing cost-effective solutions. Addressing affordability and training barriers remains important for expanding atherectomy device adoption.

OPPORTUNITY

"Expansion of cardiovascular care infrastructure creates market opportunities."

The Atherectomy Devices Market has significant opportunities through healthcare infrastructure expansion, advanced vascular treatment adoption, and technological innovation. North America represents approximately 45% of market demand due to advanced healthcare systems, high procedure adoption, and strong medical technology investment. Manufacturers are developing improved atherectomy systems with enhanced navigation, better lesion treatment capabilities, and advanced imaging compatibility. Growing demand for minimally invasive procedures is creating opportunities across hospitals, ambulatory surgical centers, and specialized clinics. Emerging markets are improving cardiovascular care infrastructure, creating additional growth opportunities. Companies are investing in research and development to introduce more efficient and patient-focused devices. Opportunities include combination therapies, improved catheter technologies, and expanded clinical applications. Increasing focus on preventive cardiovascular care and advanced treatment solutions continues supporting market expansion.

CHALLENGE

"Managing clinical risks and technological advancement requirements."

The Atherectomy Devices Market faces challenges related to procedural risks, regulatory requirements, competition, and continuous technology development. Clinics represent approximately 15% of market demand and often require efficient, cost-effective solutions for vascular procedures. Manufacturers must ensure device safety, reliability, and clinical effectiveness while meeting strict healthcare regulations. Competition among medical device companies requires continuous innovation and investment in product development. Healthcare providers also require adequate training to use advanced atherectomy technologies effectively. Companies must balance innovation with affordability while improving patient outcomes. Research into improved materials, catheter designs, and procedural techniques is essential for addressing industry challenges. Continuous technological advancement and clinical validation remain important factors influencing market growth and competitive positioning.

Atherectomy Devices Market Segmentation

The Atherectomy Devices Market is segmented by type into Directional Atherectomy Devices, Orbital Atherectomy Devices, Rotational Atherectomy Devices, and Laser Atherectomy Devices. Directional Atherectomy Devices lead with approximately 35% market share due to targeted plaque removal and procedural flexibility. Application segmentation includes Hospitals, ASCs, and Clinics. Hospitals dominate with approximately 60% market share because of advanced healthcare infrastructure and complex vascular procedure capabilities. Market growth is influenced by cardiovascular disease prevalence, technological innovation, and adoption of minimally invasive treatments.

By Type

Based on Type the global market can be categorized in to Directional Atherectomy Devices, Orbital Atherectomy Devices, Rotational Atherectomy Devices, Laser Atherectomy Devices.

• Directional Atherectomy Devices: Directional Atherectomy Devices dominate the Atherectomy Devices Market with approximately 35% share due to targeted plaque removal capability, procedural control, and broad clinical adoption. These devices allow physicians to selectively remove plaque from blood vessels while supporting vessel preparation before other interventions. Manufacturers are improving catheter designs, cutting mechanisms, and navigation systems to enhance procedural accuracy. The segment benefits from increasing demand for minimally invasive vascular treatments and improved patient outcomes. Companies are focusing on device flexibility, safety improvements, and advanced engineering. Opportunities include complex lesion treatment, improved catheter technologies, and expanded clinical applications. Growing adoption of precise plaque removal techniques continues supporting the leadership position of directional atherectomy devices.

• Orbital Atherectomy Devices: Orbital Atherectomy Devices represent approximately 25% share of the Atherectomy Devices Market and are used for treating calcified vascular lesions through orbital sanding technology. These devices help physicians manage complex plaque conditions and improve vessel preparation. Manufacturers are focusing on improving device performance, safety features, and procedural efficiency. The segment benefits from increasing demand for advanced cardiovascular interventions and treatment of complex vascular conditions. Companies are investing in technology improvements and clinical research to expand applications. Opportunities include advanced lesion modification procedures and improved treatment strategies. Growing need for effective plaque management solutions continues supporting orbital atherectomy adoption.

• Rotational Atherectomy Devices: Rotational Atherectomy Devices account for approximately 25% share of the Atherectomy Devices Market and are used for removing hardened plaque through rotational cutting mechanisms. These devices are commonly utilized in complex cardiovascular procedures where calcified lesions require specialized treatment approaches. Manufacturers are focusing on improving rotational speed control, device flexibility, and procedural safety. The segment benefits from increasing demand for advanced plaque modification techniques and minimally invasive cardiovascular procedures. Companies are investing in technology improvements and clinical applications to enhance device performance. Opportunities include complex lesion treatment, improved catheter systems, and integration with advanced imaging technologies. Growing adoption of specialized cardiovascular interventions continues supporting rotational atherectomy device development.

• Laser Atherectomy Devices: Laser Atherectomy Devices represent approximately 15% share of the Atherectomy Devices Market and use laser energy technology to remove plaque and restore vessel pathways. These devices are utilized in specialized vascular procedures requiring precise tissue removal. Manufacturers are developing advanced laser systems with improved accuracy, safety features, and procedural efficiency. The segment benefits from increasing demand for minimally invasive treatment options and advanced cardiovascular technologies. Companies are focusing on improving laser catheter designs and expanding clinical applications. Opportunities include complex vascular interventions, improved imaging integration, and enhanced treatment outcomes. Continuous innovation in laser-based vascular technologies supports segment growth.

By Application

Based on Application the global market can be categorized in to Hospitals, ASCs, Clinics.

• Hospitals: Hospitals dominate the Atherectomy Devices Market with approximately 60% share due to advanced healthcare infrastructure, specialized cardiovascular departments, and availability of complex procedural capabilities. Hospitals perform a significant number of vascular interventions requiring advanced atherectomy systems and experienced medical professionals. Manufacturers are developing devices that improve procedural efficiency, safety, and clinical outcomes. The segment benefits from increasing investment in healthcare infrastructure, cardiovascular disease management, and minimally invasive treatment adoption. Companies are partnering with healthcare providers to expand device utilization and clinical training programs. Opportunities include advanced treatment centers, digital healthcare integration, and improved procedural technologies. Growing demand for specialized cardiovascular care continues maintaining hospitals as the leading application segment.

• ASCs: Ambulatory Surgical Centers represent approximately 25% share of the Atherectomy Devices Market and are gaining importance due to increasing preference for outpatient vascular procedures. ASCs provide cost-efficient treatment environments with shorter patient recovery periods. Manufacturers are developing compact, efficient atherectomy systems suitable for outpatient settings. The segment benefits from healthcare cost optimization, technological improvements, and increasing adoption of minimally invasive procedures. Companies are focusing on simplified device operation and improved procedural efficiency. Opportunities include expanded outpatient cardiovascular services and advanced vascular treatment capabilities. Growing acceptance of ambulatory procedures continues supporting ASC adoption of atherectomy technologies.

• Clinics: Clinics represent approximately 15% share of the Atherectomy Devices Market and provide specialized vascular care services in smaller healthcare settings. These facilities are adopting advanced devices to improve patient access to cardiovascular treatments. Manufacturers are focusing on developing user-friendly systems suitable for clinic environments. The segment benefits from increasing demand for localized healthcare services and early vascular disease management. Opportunities include compact device solutions, improved training programs, and expanded access to minimally invasive procedures. Companies are working to improve affordability and accessibility of atherectomy technologies for smaller healthcare providers.

Atherectomy Devices Market Regional Outlook

• North America

North America represents approximately 45% share of the Atherectomy Devices Market due to advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong presence of medical technology companies. The USA contributes significantly through advanced cardiovascular treatment facilities and growing demand for vascular intervention procedures. Hospitals represent approximately 60% of global demand, supporting strong regional adoption.

The region benefits from companies including Boston Scientific Corp., Medtronic Plc, and other leading medical device manufacturers. Healthcare providers are investing in advanced atherectomy systems to improve patient outcomes and procedural efficiency. Manufacturers are focusing on next-generation catheter technologies, improved imaging compatibility, and enhanced safety features. Opportunities include outpatient procedure expansion, healthcare modernization, and advanced cardiovascular care solutions. Strong research capabilities and medical innovation continue supporting North America's leadership position.

• Europe

Europe accounts for approximately 25% share of the Atherectomy Devices Market and is supported by advanced healthcare systems, cardiovascular treatment capabilities, and increasing adoption of minimally invasive procedures. Countries including Germany, France, the United Kingdom, and Italy contribute significantly to regional demand.

European healthcare providers are focusing on improving vascular disease management and adopting advanced medical technologies. Manufacturers are developing efficient atherectomy systems with improved safety and performance features. Opportunities include healthcare modernization, specialized vascular centers, and advanced treatment solutions. Increasing awareness of cardiovascular care continues supporting regional market development.

• Asia-Pacific

Asia-Pacific represents approximately 20% share of the Atherectomy Devices Market and is supported by healthcare infrastructure expansion, rising cardiovascular disease awareness, and increasing medical technology adoption. Countries including China, Japan, India, and South Korea contribute significantly to regional growth.

The region benefits from growing healthcare investments and increasing demand for advanced cardiovascular procedures. Manufacturers are expanding distribution networks and introducing cost-effective solutions. Opportunities include hospital modernization, specialized clinics, and improved access to minimally invasive treatments. Growing healthcare development continues supporting Asia-Pacific market expansion.

• Middle East & Africa

Middle East & Africa represents approximately 6% share of the Atherectomy Devices Market and is developing through healthcare infrastructure improvements and increasing cardiovascular care requirements. Countries including Saudi Arabia, the United Arab Emirates, and South Africa contribute to regional demand.

Healthcare providers are investing in advanced medical technologies and specialized treatment capabilities. Manufacturers are expanding regional presence through partnerships and distribution networks. Opportunities include cardiovascular centers, hospital upgrades, and advanced treatment adoption. Improving healthcare access continues supporting regional market growth.

• Rest of the World

Rest of the World accounts for approximately 4% share of the Atherectomy Devices Market and includes Latin America and emerging healthcare markets. Countries such as Brazil and Mexico contribute through expanding cardiovascular treatment services.

Demand is supported by healthcare improvements, increasing disease awareness, and adoption of minimally invasive procedures. Companies are focusing on expanding availability and improving affordability. Opportunities include healthcare modernization and specialized vascular treatment services.

Key Industry Players

The Atherectomy Devices Market includes global medical device companies focusing on vascular intervention technologies, catheter systems, and minimally invasive treatment solutions. Boston Scientific Corp. and Medtronic Plc maintain strong market positions through advanced cardiovascular devices, research capabilities, and global healthcare networks. Cardiovascular Systems Inc., Spectranetics Corp., Avinger Inc., Royal Philips NV, and Terumo Corp. compete through product innovation, clinical development, and advanced vascular technologies. Companies are investing in improved catheter designs, imaging integration, and procedural efficiency. Competitive strategies include expanding product portfolios, strengthening healthcare partnerships, and developing next-generation atherectomy solutions.

List of Top Atherectomy Devices Companies

• Boston Scientific Corp.
• Cardiovascular Systems Inc.
• Medtronic Plc
• Spectranetics Corp.
• Avinger Inc.
• Royal Philips NV
• Terumo Corp.

Top Two Companies Market Share

• Boston Scientific Corp.: holds an estimated 18% share through vascular innovation and advanced atherectomy solutions.

• Medtronic Plc: holds an estimated 15% share through cardiovascular technologies and global medical presence.

Investment Analysis and Opportunities

Investment opportunities in the Atherectomy Devices Market are increasing through cardiovascular technology development, minimally invasive procedures, and healthcare infrastructure expansion. North America represents approximately 45% market share, creating opportunities through advanced medical systems and high procedure adoption. Companies are investing in next-generation catheter technologies, digital healthcare integration, and improved treatment solutions. Additional opportunities exist in ambulatory surgical centers, emerging healthcare markets, and advanced vascular care facilities. Growing demand for efficient cardiovascular treatments encourages innovation. Companies focusing on clinical performance, affordability, and technological advancement can strengthen their competitive position.

New Product Development

New product development in the Atherectomy Devices Market focuses on improved catheter systems, advanced plaque removal technologies, and enhanced procedural safety. Directional Atherectomy Devices represent approximately 35% of demand, encouraging manufacturers to improve precision and flexibility. Companies are developing devices with better navigation capabilities, imaging compatibility, and improved treatment outcomes. Innovation includes advanced materials, smaller device profiles, and enhanced usability. Manufacturers are also focusing on expanding applications across hospitals, ASCs, and clinics. Continuous product development is improving vascular treatment efficiency and patient care quality.

Recent Developments

• March 2025 – Boston Scientific Corp. – Boston Scientific advances vascular atherectomy technology solutions.

Boston Scientific improved atherectomy technologies through product innovation, clinical advancement, and procedural improvements.

• June 2025 – Medtronic Plc – Medtronic expands cardiovascular device portfolio through innovation.

Medtronic developed advanced vascular solutions through research, technology improvements, and clinical applications.

• September 2025 – Cardiovascular Systems Inc. – CSI enhances atherectomy treatment capabilities.

Cardiovascular Systems Inc. improved devices through engineering innovation, procedural efficiency, and vascular technology development.

• February 2026 – Terumo Corp. – Terumo develops advanced vascular intervention technologies.

Terumo enhanced cardiovascular solutions through product development, precision technologies, and healthcare innovation.

• July 2026 – Royal Philips NV – Philips strengthens vascular imaging and treatment solutions.

Royal Philips NV improved vascular care through imaging integration, technology advancement, and clinical solutions.

Report Coverage

The Atherectomy Devices Market report covers product types, applications, regional analysis, competitive landscape, investment opportunities, and product innovation. Type analysis includes Directional Atherectomy Devices, Orbital Atherectomy Devices, Rotational Atherectomy Devices, and Laser Atherectomy Devices. Application analysis covers Hospitals, ASCs, and Clinics. The report evaluates vascular intervention technologies, catheter systems, minimally invasive procedures, cardiovascular treatment trends, and medical device innovation. Regional coverage includes North America, Europe, Asia-Pacific, Middle East & Africa, and Rest of the World. Company analysis includes leading medical device manufacturers, product strategies, technological developments, partnerships, and competitive positioning across the global Atherectomy Devices Market.